Thus, a multi-targets approach for PET imaging of microglia activation, combining TSPO radiopharmaceuticals with new probes specific of P2X7 expression may help to characterize the involvement of neuroinflammation over the CNS disorder’s progression, as well as to follow the effects of clinical treatments on microglia polarization. Here, TSPO is linked to central nervous system disorder.